Literature DB >> 9235985

Solution structures of the R6 human insulin hexamer,.

X Chang1, A M Jorgensen, P Bardrum, J J Led.   

Abstract

The three-dimensional solution structure of the phenol-stabilized 36 kDa R6 insulin hexamer was determined by NMR spectroscopy and restrained molecular dynamics. The hexamer structures were derived using a stepwise procedure. Initially, 60 monomers were obtained by distance geometry from 665 NOE-derived distance restraints and three disulfide bridges. Subsequently, the hexamer structures were calculated by simulated annealing, using 30 hexamers constructed from the best 36 monomer structures as the starting models. The NMR data show that the aromatic ring of residue Phe(B25) can take two different orientations in the solution hexamer: one in which it points inward (molecule 1, about 90%) and one in which it points outward from the surface of the monomer (molecule 2, about 10%). Therefore, two hexamer structures were calculated: a symmetric hexamer consisting of six molecule 1 monomers and a nonsymmetric hexamer consisting of five molecule 1 monomers and one molecule 2 monomer. For each of the six monomers, the restraints used in the calculations of the hexamer structures include, in addition to the intramonomeric restraints, 25 NOEs between insulin and phenol, 23 NOEs and two hydrogen bonds across the dimer interface, nine NOEs across the trimer interface, and five intramonomeric or two intermonomeric NOEs, respectively, specifying the different orientations of the Phe(B25) ring. The coordination of the two Zn atoms was defined by eight distance restraints. Thus, a total of 4394 and 4391 distance restraints, respectively, were used in the two hexamer calculations. The NOE restraints were classified in an iterative process as intra- or intermonomeric on the basis of their consistency or inconsistency with the structure of the monomer. The assignment of the dimer- and trimer-specific NOEs was made using the crystal structure of the R6 hexamer as the starting model. For both solution hexamers, the average backbone rms deviation is 0.81 A, if the less well-defined N- and C-terminal residues are excluded. The corresponding rms deviations for all heavy atoms are 1.17 and 1.19 A for the nonsymmetric and symmetric hexamer, respectively. The overall solution structure of the R6 insulin hexamer is compact, rigid, and symmetric and resembles the corresponding crystal structure. However, the extension of the B-chain alpha-helix, which characterizes the R state, is shorter in the solution structure than in the crystal structure. Also, the study shows that the orientation of the Phe(B25) ring has no effect on the structure of the rest of the molecule, within the uncertainty of the structure determination. The importance of these findings for the current model for the insulin-receptor interaction is discussed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9235985     DOI: 10.1021/bi9631069

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  29 in total

1.  Unraveling the symmetry ambiguity in a hexamer: calculation of the R6 human insulin structure.

Authors:  S I O'Donoghue; X Chang; R Abseher; M Nilges; J J Led
Journal:  J Biomol NMR       Date:  2000-02       Impact factor: 2.835

2.  Recombinant A22(G)-B31 (R)-human insulin. A22 addition introduces conformational mobility in B chain C-terminus.

Authors:  Piotr Borowicz; Elżbieta Bednarek; Wojciech Bocian; Jerzy Sitkowski; Beata Jaworska; Jerzy Mikołajczyk; Tadeusz Głąbski; Dorota Stadnik; Weronika Surmacz; Monika Bogiel; Lech Kozerski
Journal:  J Biomol NMR       Date:  2012-02-14       Impact factor: 2.835

3.  Probing the nucleus model for oligomer formation during insulin amyloid fibrillogenesis.

Authors:  Leonard F Pease; Mirco Sorci; Suvajyoti Guha; De-Hao Tsai; Michael R Zachariah; Michael J Tarlov; Georges Belfort
Journal:  Biophys J       Date:  2010-12-15       Impact factor: 4.033

4.  Amyloidogenic self-assembly of insulin aggregates probed by high resolution atomic force microscopy.

Authors:  Ralf Jansen; Wojciech Dzwolak; Roland Winter
Journal:  Biophys J       Date:  2004-12-01       Impact factor: 4.033

5.  Design of an active ultrastable single-chain insulin analog: synthesis, structure, and therapeutic implications.

Authors:  Qing-xin Hua; Satoe H Nakagawa; Wenhua Jia; Kun Huang; Nelson B Phillips; Shi-quan Hu; Michael A Weiss
Journal:  J Biol Chem       Date:  2008-03-10       Impact factor: 5.157

6.  Structure-based stabilization of insulin as a therapeutic protein assembly via enhanced aromatic-aromatic interactions.

Authors:  Nischay K Rege; Nalinda P Wickramasinghe; Alisar N Tustan; Nelson F B Phillips; Vivien C Yee; Faramarz Ismail-Beigi; Michael A Weiss
Journal:  J Biol Chem       Date:  2018-06-07       Impact factor: 5.157

7.  Insulin Release Dynamics from Poly(diethylaminoethyl methacrylate) Hydrogel Systems.

Authors:  Steve R Marek; Nicholas A Peppas
Journal:  AIChE J       Date:  2013-10-01       Impact factor: 3.993

8.  Structural signatures of the complex formed between 3-nitro-4-hydroxybenzoate and the Zn(II)-substituted R(6) insulin hexamer.

Authors:  Helle Birk Olsen; Melissa R Leuenberger-Fisher; Webe Kadima; Dan Borchardt; Niels C Kaarsholm; Michael F Dunn
Journal:  Protein Sci       Date:  2003-09       Impact factor: 6.725

9.  Ligand escape pathways and (un)binding free energy calculations for the hexameric insulin-phenol complex.

Authors:  Harish Vashisth; Cameron F Abrams
Journal:  Biophys J       Date:  2008-08-01       Impact factor: 4.033

10.  Chemometric Methods to Quantify 1D and 2D NMR Spectral Differences Among Similar Protein Therapeutics.

Authors:  Kang Chen; Junyong Park; Feng Li; Sharadrao M Patil; David A Keire
Journal:  AAPS PharmSciTech       Date:  2017-11-06       Impact factor: 3.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.